MARKET

TOIIW

TOIIW

The Oncology Institute Inc
NASDAQ
0.1302
0.0000
0.00%
Closed 16:00 02/08 EST
OPEN
0.1302
PREV CLOSE
0.1302
HIGH
0.1302
LOW
0.1302
VOLUME
1
TURNOVER
--
52 WEEK HIGH
1.503
52 WEEK LOW
0.0551
MARKET CAP
--
P/E (TTM)
-6.5428
1D
5D
1M
3M
1Y
5Y
BRIEF-Oncology Institute Rebrands Clinical Trials Division
Reuters · 12/15/2022 13:18
BRIEF-The Oncology Institute Reports Third Quarter 2022 Financial Results
Reuters · 11/09/2022 21:44
The Oncology Institute Announces Third Quarter 2022 Earnings Release Date and Conference Call
CERRITOS, Calif., Oct. 19, 2022 (GLOBE NEWSWIRE) -- The Oncology Institute, LLC (“TOI”) (NASDAQ: TOI) one of the largest value-based oncology groups in the United States, today announced that the company will release its third quarter results after the mar...
GlobeNewswire · 10/19/2022 12:00
The Oncology Institute Executives to Speak at Key Industry Conferences in Q4
Publicly traded company leaders will share perspectives on the future of value-based oncology careCERRITOS, Calif., Oct. 17, 2022 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc (NASDAQ: TOI), one of the largest value-based oncology groups in the United St...
GlobeNewswire · 10/17/2022 20:05
The Oncology Institute Announces New Leaders to Oversee Technology and Clinical Trials
Phil Reger and Cristina Green Will Serve as the Chief Information Officer and Vice President of Clinical Research, RespectivelyCERRITOS, Calif., Oct. 11, 2022 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based on...
GlobeNewswire · 10/11/2022 12:00
BRIEF-The Oncology Institute Appoints Two New Board Members
BRIEF-The Oncology Institute Appoints Two New Board Members
Reuters · 09/22/2022 20:12
The Oncology Institute to Participate at the Nephron 2nd Annual Physician Enablement Symposium
CERRITOS, Calif., Sept. 15, 2022 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based oncology groups in the United States, today announced that its Chief Executive Officer, Brad Hively, will participate on the “Ne...
GlobeNewswire · 09/15/2022 12:00
The Oncology Institute to Participate at the Baird Newly Public Company Virtual Access Day
CERRITOS, Calif., Aug. 16, 2022 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based community oncology groups in the United States, today announced that its Chief Executive Officer, Brad Hively, and its Chief Fina...
GlobeNewswire · 08/16/2022 12:00
More
About TOIIW
The Oncology Institute, Inc. is a value-based oncology company. The Company manages community-based oncology practices that serve patients at approximately 67 clinic locations across 11 markets and four states throughout the United States. Its managed clinics provide a range of medical oncology services, including physician services, in-house infusion, and dispensary, clinical trial services, radiation, programs like outpatient stem cell transplants and transfusions, along with 24/7 patient support. It offers cutting-edge treatment through clinical trials. It also offers convenient, safe appointments via telehealth. The Company through Innovative Clinical Research Institute, LLC (ICRI), provides and manages clinical trial services and research for the benefit of cancer patients. The Company's segment includes patient care, dispensary, and clinical trials & other. Its managed clinics primarily serve adult and senior cancer patients in markets that have Medicare Advantage (MA) plans.

Webull offers kinds of Oncology Institute Inc stock information, including NASDAQ:TOIIW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TOIIW stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading TOIIW stock methods without spending real money on the virtual paper trading platform.